SDGR - Schrödinger, Inc.
NASDAQ
->
Healthcare
->
Health Information Services
New York,
United States
Type: Equity
SDGR price evolution
SDGR
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $112.34 | $134.87 | $161.07 | |
| Short term investments | $269.18 | $300.84 | $307.69 | |
| Net receivables | $44.82 | $52.17 | $45.62 | $89.12 |
| Inventory | ||||
| Total current assets | $456.4 | $449.18 | $493.69 | $567.8 |
| Long term investments | $88.56 | $91.39 | $83.25 | |
| Property, plant & equipment | $137.74 | $142.25 | $144.71 | $141.1 |
| Goodwill & intangible assets | $4.79 | $4.79 | $4.79 | |
| Total noncurrent assets | $239.19 | $244.08 | $235.16 | |
| Total investments | $357.74 | $392.23 | $390.94 | |
| Total assets | $669.3 | $688.37 | $737.76 | $802.96 |
| Current liabilities | ||||
| Accounts payable | $11.21 | $8.12 | $9.97 | $16.82 |
| Deferred revenue | $47.88 | $57.51 | $65.27 | |
| Short long term debt | $16.8 | $16.93 | $16.87 | |
| Total current liabilities | $111.12 | $99.76 | $106.51 | $133.67 |
| Long term debt | $107.13 | $108.99 | $111.01 | |
| Total noncurrent liabilities | $114.63 | $117.55 | $120.72 | |
| Total debt | $123.93 | $125.92 | $127.88 | |
| Total liabilities | $219.87 | $214.39 | $224.06 | $254.4 |
| Shareholders' equity | ||||
| Retained earnings | -$485.32 | -$447.19 | -$393.14 | -$338.42 |
| Other shareholder equity | $0.6 | -$0.18 | -$0.07 | $0.28 |
| Total shareholder equity | $473.98 | $513.71 | $548.56 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $161.07 | $95.72 | $123.27 | $202.8 |
| Short term investments | $307.69 | $360.61 | $456.21 | $440.39 |
| Net receivables | $89.12 | $69.09 | $40.55 | $35.38 |
| Inventory | ||||
| Total current assets | $567.8 | $533.99 | $625.06 | $682.98 |
| Long term investments | $83.25 | $25.68 | $43.17 | $45.66 |
| Property, plant & equipment | $141.1 | $120.23 | $85.41 | $15.27 |
| Goodwill & intangible assets | $4.79 | $5.38 | ||
| Total noncurrent assets | $235.16 | $154.6 | $131.43 | $63.28 |
| Total investments | $390.94 | $386.3 | $499.38 | $486.06 |
| Total assets | $802.96 | $688.59 | $756.49 | $746.26 |
| Current liabilities | ||||
| Accounts payable | $16.82 | $9.47 | $8.08 | $8.4 |
| Deferred revenue | $65.27 | $83.53 | $85.43 | $86.57 |
| Short long term debt | $16.87 | $11.01 | $2.04 | $4.54 |
| Total current liabilities | $133.67 | $108.8 | $91.21 | $73.2 |
| Long term debt | $111.01 | $105.48 | $77.83 | $7.22 |
| Total noncurrent liabilities | $120.72 | $131.88 | $108.19 | $49.04 |
| Total debt | $127.88 | $116.49 | $79.87 | $11.76 |
| Total liabilities | $254.4 | $240.69 | $199.4 | $122.24 |
| Shareholders' equity | ||||
| Retained earnings | -$338.42 | -$379.14 | -$229.95 | -$129.56 |
| Other shareholder equity | $0.28 | -$2.38 | -$0.65 | $0.32 |
| Total shareholder equity | $548.56 | $447.89 | $557.07 | $624.01 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $47.33 | $36.6 | $74.13 | |
| Cost of revenue | $16 | $17.71 | $16.58 | |
| Gross Profit | $31.34 | $18.89 | $57.55 | |
| Operating activities | ||||
| Research & development | $50.84 | $50.61 | $51.49 | |
| Selling, general & administrative | $33.23 | $35.71 | $35.68 | |
| Total operating expenses | $84.06 | $86.32 | $87.17 | |
| Operating income | -$52.73 | -$67.43 | -$29.62 | |
| Income from continuing operations | ||||
| EBIT | -$53.96 | -$54.27 | -$31.51 | |
| Income tax expense | $0.08 | $0.46 | -$0.84 | |
| Interest expense | ||||
| Net income | ||||
| Net income | -$54.05 | -$54.72 | -$30.67 | |
| Income (for common shares) | -$54.05 | -$54.72 | -$30.67 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $216.67 | $180.96 | $137.93 | $108.09 |
| Cost of revenue | $75.97 | $79.93 | $72.31 | $44.62 |
| Gross Profit | $140.69 | $101.02 | $65.62 | $63.47 |
| Operating activities | ||||
| Research & development | $181.77 | $126.37 | $90.9 | $64.69 |
| Selling, general & administrative | $136.37 | $121.47 | $86.16 | $59.69 |
| Total operating expenses | $318.14 | $247.84 | $177.06 | $124.39 |
| Operating income | -$177.45 | -$146.82 | -$111.44 | -$60.92 |
| Income from continuing operations | ||||
| EBIT | $42.92 | -$149.12 | -$99.98 | -$24.12 |
| Income tax expense | $2.2 | $0.06 | $0.41 | $0.34 |
| Interest expense | ||||
| Net income | ||||
| Net income | $40.72 | -$149.19 | -$100.39 | -$24.46 |
| Income (for common shares) | $40.72 | -$149.19 | -$100.39 | -$24.46 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$54.05 | -$54.72 | -$30.67 | |
| Operating activities | ||||
| Depreciation | $3.45 | $3.59 | $3.4 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $12.81 | $12.22 | $12.53 | |
| Total cash flows from operations | -$53.72 | -$39.28 | -$37.26 | |
| Investing activities | ||||
| Capital expenditures | -$1 | -$4.09 | -$2.48 | |
| Investments | $30.58 | $9.17 | -$57.13 | |
| Total cash flows from investing | $125.36 | $29.58 | $5.08 | -$59.61 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.62 | $8.02 | $2.34 | |
| Net borrowings | -$0.01 | -$0.01 | -$0.01 | |
| Total cash flows from financing | $10 | $1.61 | $8.01 | $2.33 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $9.11 | -$22.54 | -$26.19 | -$94.54 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $40.72 | -$149.19 | -$100.39 | -$24.46 |
| Operating activities | ||||
| Depreciation | $13.32 | $11.63 | $8.65 | $9 |
| Business acquisitions & disposals | -$6.43 | |||
| Stock-based compensation | $47.84 | $39.63 | $26.49 | $10.54 |
| Total cash flows from operations | -$136.73 | -$119.68 | -$70.67 | $16.76 |
| Investing activities | ||||
| Capital expenditures | -$13.4 | -$8.01 | -$7.17 | -$2.54 |
| Investments | $206.44 | $104.46 | -$9.64 | -$379.18 |
| Total cash flows from investing | $193.03 | $90.02 | -$16.81 | -$381.72 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $9.44 | $2.11 | $7.93 | $541.27 |
| Net borrowings | -$0.02 | |||
| Total cash flows from financing | $9.05 | $2.11 | $7.95 | $541.27 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $65.35 | -$27.55 | -$79.53 | $176.31 |
News
Fundamentals
| Market cap | $1.41B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 72.85M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.46 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 4.11 |
| Quick ratio | N/A |